JULIE GASTIER-FOSTER to Tumor Suppressor Protein p53
This is a "connection" page, showing publications JULIE GASTIER-FOSTER has written about Tumor Suppressor Protein p53.
Connection Strength
0.362
-
Genomic Profiling of Childhood Tumor Patient-Derived Xenograft Models to Enable Rational Clinical Trial Design. Cell Rep. 2019 11 05; 29(6):1675-1689.e9.
Score: 0.071
-
Genomic and Functional Approaches to Understanding Cancer Aneuploidy. Cancer Cell. 2018 04 09; 33(4):676-689.e3.
Score: 0.064
-
TP53 Germline Variations Influence the Predisposition and Prognosis of B-Cell Acute Lymphoblastic Leukemia in Children. J Clin Oncol. 2018 02 20; 36(6):591-599.
Score: 0.063
-
Significance of TP53 Mutation in Wilms Tumors with Diffuse Anaplasia: A Report from the Children's Oncology Group. Clin Cancer Res. 2016 Nov 15; 22(22):5582-5591.
Score: 0.057
-
Germline TP53 variants and susceptibility to osteosarcoma. J Natl Cancer Inst. 2015 Jul; 107(7).
Score: 0.052
-
Oncogenic Signaling Pathways in The Cancer Genome Atlas. Cell. 2018 04 05; 173(2):321-337.e10.
Score: 0.016
-
Systematic Analysis of Splice-Site-Creating Mutations in Cancer. Cell Rep. 2018 04 03; 23(1):270-281.e3.
Score: 0.016
-
Rise and fall of subclones from diagnosis to relapse in pediatric B-acute lymphoblastic leukaemia. Nat Commun. 2015 Mar 19; 6:6604.
Score: 0.013
-
The genomic landscape of hypodiploid acute lymphoblastic leukemia. Nat Genet. 2013 Mar; 45(3):242-52.
Score: 0.011